Works by Li-ting Liu


Results: 60
    1
    2
    3

    Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study.

    Published in:
    European Radiology, 2021, v. 31, n. 7, p. 5222, doi. 10.1007/s00330-020-07478-1
    By:
    • Xiao, Bei-Bei;
    • Chen, Qiu-Yan;
    • Sun, Xue-Song;
    • Li, Ji-Bin;
    • Luo, Dong-hua;
    • Sun, Rui;
    • Lin, Da-Feng;
    • Zhang, Xu;
    • Fan, Wei;
    • Lv, Xiao-Fei;
    • Han, Lu-Jun;
    • Wen, Yue-Feng;
    • Yuan, Li;
    • Guo, Shan-Shan;
    • Liu, Li-Ting;
    • Liu, Sai-Lan;
    • Tang, Qing-Nan;
    • Liang, Yu-Jing;
    • Li, Xiao-Yun;
    • Lin, Chao
    Publication type:
    Article
    4
    5
    6
    7
    8

    Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 3, p. 861, doi. 10.4143/crt.2017.237
    By:
    • Qiu-Yan Chen;
    • Shao-Yan Guo;
    • Lin-Quan Tang;
    • Tong-Yu Lu;
    • Bo-Lin Chen;
    • Qi-Yu Zhong;
    • Meng-Sha Zou;
    • Qing-Nan Tang;
    • Wen-Hui Chen;
    • Shan-Shan Guo;
    • Li-Ting Liu;
    • Yang Li;
    • Ling Guo;
    • Hao-Yuan Mo;
    • Rui Sun;
    • Dong-Hua Luo;
    • Chong Zhao;
    • Ka-Jia Cao;
    • Chao-Nan Qian;
    • Xiang Guo
    Publication type:
    Article
    9

    Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 3, p. 701, doi. 10.4143/crt.2017.180
    By:
    • Qiu-Yan Chen;
    • Qing-Nan Tang;
    • Lin-Quan Tang;
    • Wen-Hui Chen;
    • Shan-Shan Guo;
    • Li-Ting Liu;
    • Chao-Feng Li;
    • Yang Li;
    • Yu-Jing Liang;
    • Xue-Song Sun;
    • Ling Guo;
    • Hao-Yuan Mo;
    • Rui Sun;
    • Dong-Hua Luo;
    • Yu-Ying Fan;
    • Yan He;
    • Ming-Yuan Chen;
    • Ka-Jia Cao;
    • Chao-Nan Qian;
    • Xiang Guo
    Publication type:
    Article
    10
    11
    12

    Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928214
    By:
    • Liu, Li-Ting;
    • Liang, Yu-Jing;
    • Guo, Shan-Shan;
    • Mo, Hao-Yuan;
    • Guo, Ling;
    • Wen, Yue-Feng;
    • Xie, Hao-Jun;
    • Tang, Qing-Nan;
    • Sun, Xue-Song;
    • Liu, Sai-Lan;
    • Li, Xiao-Yun;
    • Yang, Jin-Hao;
    • Yang, Zhen-Chong;
    • Tang, Lin-Quan;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    13

    Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.

    Published in:
    BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-03164-3
    By:
    • Liu, Ting;
    • Dong, Di;
    • Zhao, Xun;
    • Ou, Xiao-Min;
    • Yi, Jun-Lin;
    • Guan, Jian;
    • Zhang, Ye;
    • Xiao-Fei, Lv;
    • Xie, Chuan-Miao;
    • Luo, Dong-Hua;
    • Sun, Rui;
    • Chen, Qiu-Yan;
    • Xing, Lv;
    • Guo, Shan-Shan;
    • Liu, Li-Ting;
    • Lin, Da-Feng;
    • Chen, Yan-Zhou;
    • Lin, Jie-Yi;
    • Luo, Mei-Juan;
    • Yan, Wen-Bin
    Publication type:
    Article
    14
    15
    16
    17
    18

    Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 12, p. e2138470, doi. 10.1001/jamanetworkopen.2021.38470
    By:
    • Tang, Qing-Nan;
    • Liu, Li-Ting;
    • Qi, Bin;
    • Guo, Shan-Shan;
    • Luo, Dong-Hua;
    • Sun, Rui;
    • Sun, Xue-Song;
    • Chen, Dong-Ping;
    • Guo, Ling;
    • Mo, Hao-Yuan;
    • Wang, Pan;
    • Liu, Sai-Lan;
    • Liang, Yu-Jing;
    • Li, Xiao-Yun;
    • Yang, Zhen-Chong;
    • Chen, Qiu-Yan;
    • Mai, Hai-Qiang;
    • Tang, Lin-Quan
    Publication type:
    Article
    19

    Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [<sup>18</sup>F]‐fluorodeoxyglucose positron emission tomography

    Published in:
    Cancer Medicine, 2020, v. 9, n. 23, p. 8852, doi. 10.1002/cam4.3500
    By:
    • Xie, Hao‐Jun;
    • Yu, Yi‐Fei;
    • Sun, Xue‐Song;
    • Jia, Guo‐Dong;
    • Luo, Dong‐Hua;
    • Sun, Rui;
    • Liu, Li‐Ting;
    • Guo, Shan‐Shan;
    • Liu, Sai‐Lan;
    • Chen, Qiu‐Yan;
    • Tang, Lin‐Quan;
    • Mai, Hai‐Qiang
    Publication type:
    Article
    20

    Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 9, p. 4214, doi. 10.1002/cam4.2343
    By:
    • Sun, Xue‐Song;
    • Chen, Wen‐Hui;
    • Liu, Sai‐Lan;
    • Liang, Yu‐Jing;
    • Chen, Qiu‐Yan;
    • Guo, Shan‐Shan;
    • Wen, Yue‐Feng;
    • Liu, Li‐Ting;
    • Xie, Hao‐Jun;
    • Tang, Qing‐Nan;
    • Li, Xiao‐Yun;
    • Yan, Jin‐Jie;
    • Mai, Hai‐Qiang;
    • Tang, Lin‐Quan
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 8, p. 2586, doi. 10.1007/s00259-020-05128-8
    By:
    • Xiao, Bei-Bei;
    • Lin, Da-Feng;
    • Sun, Xue-Song;
    • Zhang, Xu;
    • Guo, Shan-Shan;
    • Liu, Li-Ting;
    • Luo, Dong-hua;
    • Sun, Rui;
    • Wen, Yue-Feng;
    • Li, Ji-Bin;
    • Lv, Xiao-Fei;
    • Han, Lu-Jun;
    • Yuan, Li;
    • Liu, Sai-Lan;
    • Tang, Qing-Nan;
    • Liang, Yu-Jing;
    • Li, Xiao-Yun;
    • Guo, Ling;
    • Chen, Qiu-Yan;
    • Fan, Wei
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40402-x
    By:
    • Yuan, Li;
    • Jia, Guo-Dong;
    • Lv, Xiao-Fei;
    • Xie, Si-Yi;
    • Guo, Shan-Shan;
    • Lin, Da-Feng;
    • Liu, Li-Ting;
    • Luo, Dong-Hua;
    • Li, Yi-Fu;
    • Deng, Shen-Wen;
    • Guo, Ling;
    • Zeng, Mu-Sheng;
    • Cai, Xiu-Yu;
    • Liu, Sai-Lan;
    • Sun, Xue-Song;
    • Li, Xiao-Yun;
    • Li, Su-Chen;
    • Chen, Qiu-Yan;
    • Tang, Lin-Quan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50